title: [Management of pure teratoma of the testis in adult, results of a multicenter study over 15 years].
abstract: OBJECTIVE
  To analyze cases of pure teratoma of the testis (PTT) of a large population-based study, as such tumors are rare, and to make an update on the topic.
  
  
  METHODS
  We retrospectively reviewed the records of patients treated for PTT from 1987 to 2003 in the French Midi-Pyrenees region (southwestern France) and in the Val-de-Grâce military hospital, Paris. Among more than 1000 cases of testis cancer, we identified 20 cases of PTT (4% of the whole population). For each patient, the orchiectomy specimen was reviewed and a clinical and imaging re-evaluation was performed.
  
  
  RESULTS
  The pathological re-evaluation revealed non-teratomatous components in three patients (excluded from a following analysis). For the localized PTT patients, four out of eight out of 8 were on surveillance only after the orchiectomy, and the remaining four received adjuvant chemotherapy. None of them received any lymphadenectomy for staging. All patients with the metastatic disease were treated by chemotherapy followed by surgical removal of residual tumor masses. With a mean of 125 months follow-up, 85% of the population did not relapse after treatment. At the last contact, all were alive, without the disease.
  
  
  CONCLUSIONS
  We confirm that PTT is a malignant disease with a good prognosis. As its management differs from the other non-seminomatous germ cell tumors, the diagnosis of PTT must be with certainty. The retrospective analysis of a series over two decades highlights the deviations from current guidelines. We propose that this rare tumor of young man should be treated in specialized centers to get the optimal management.
authors.affiliation: Fédération d'urologie-andrologie, hôpital Rangueil, 1, avenue Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
authors.forename: P
authors.initials: P
authors.lastname: Labarthe
authors.forename: M
authors.initials: M
authors.lastname: Khedis
authors.forename: C
authors.initials: C
authors.lastname: Chevreau
authors.forename: C
authors.initials: C
authors.lastname: Mazerolles
authors.forename: M
authors.initials: M
authors.lastname: Thoulouzan
authors.forename: X
authors.initials: X
authors.lastname: Durand
authors.forename: M
authors.initials: M
authors.lastname: Soulie
authors.forename: P
authors.initials: P
authors.lastname: Rischmann
authors.forename: P
authors.initials: P
authors.lastname: Plante
authors.forename: P
authors.initials: P
authors.lastname: Thonneau
authors.forename: A
authors.initials: A
authors.lastname: Houlgatte
authors.forename: E
authors.initials: E
authors.lastname: Huyghe
mesh_terms: D000328:Adult; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013724:Teratoma / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy*; D013997:Time Factors; D055815:Young Adult